đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This was a randomized, subject and investigator-blinded, placebo-controlled...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-07-22
Trial ID
NCT04321252
This was Cohort B2 of the Platform study (NCT05750628) to evaluate the effi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2024-01-23
Trial ID
NCT07235033
Treatments Being Tested
The purpose of this study was to identify the safe and effective dose of in...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-03-07
Trial ID
NCT04675931
Treatments Being Tested
This study will assess efficacy, safety , tolerability and PK in uncomplica...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-07
Trial ID
NCT01860989
Platform study to evaluate the efficacy and safety of anti-malarial agents ...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2024-01-23
Trial ID
NCT05750628
Treatments Being Tested
This study aims to determine the Minimum Inhibitory Concentration of KAE609...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-01
Trial ID
NCT01836458
Treatments Being Tested
This is a single-center open label study conducted in multiple sequential c...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2015-07
Trial ID
NCT02543086
Treatments Being Tested
KAE609 will be evaluated primarily for hepatic safety of single and multipl...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-11-16
Trial ID
NCT03334747
This study will assess efficacy, safety , tolerability and PK in uncomplica...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-01
Trial ID
NCT01524341
Treatments Being Tested
This is a single-centre, open-label, study using induced blood stage malari...
Status
Completed
Location
Q-Pharm Clinics, Royal Brisbane and Women's Hospital
Start Date
2016-09-13
Trial ID
NCT02867059
Treatments Being Tested